This is an amended filing
Alteogen Inc. Absorption of subsidiary Alteogen Biologics, merger date corrected to Feb 16, 2027
AI summary · Not investment advice
Alteogen absorbs its subsidiary Alteogen Biologics at a ratio of 1 : 0.1679581, and the merger date was changed to February 16, 2027.
Merger ratio
1 : 0.1679581 (Alteogen : Alteogen Biologics)
600,477 new shares to be issued
Key facts
- New share listing date
- Mar 12, 2027As corrected
- Merger counterparty
- ALTEOGEN BIOLOGICS, INC.Subsidiary
- Merger date
- Feb 16, 2027As corrected
- Merger method
- Alteogen absorbs its subsidiary Alteogen Biologics, Inc. in a merger
- Merger type
- Small-scale merger
- Appraisal rights
- Not granted (small-scale merger)
- Board resolution date
- Oct 6, 2026
Commentary
AI commentary · Not investment advice
What happened
Alteogen decided to absorb its subsidiary, Alteogen Biologics, Inc., in an absorption merger (one company takes over another, which then ceases to exist).
In the company's terms
The exchange ratio is 1 : 0.1679581. The merger creates 600,477 new common shares. It is a small-scale merger. The merger date has been changed to February 16, 2027.
What changes for shareholders
The company being merged had sales of KRW 20.487 billion in the first half of 2026. Its net income for the same period was KRW 6.298 billion.
The notice period for shareholders opposing the merger ran from October 21 to November 4, 2026. Because this is a small-scale merger, appraisal rights (the right of opposing shareholders to sell shares to the company) are not granted. Creditors can file objections from January 15 to February 15, 2027. The merger registration is scheduled for February 17, 2027. The new shares are scheduled to begin trading on March 12, 2027.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
A